Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pallud

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|March 23, 2000
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerR Lidereau, F Eisinger, M H Champème, et al.
Journal of the National Cancer Institute|January 19, 1994
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisS M Scholl, C Pallud, F Beuvon, et al.
Cancer Research|May 15, 1987
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumorsM Perrot-Applanat, M T Groyer-Picard, F Lorenzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 27, 1999
The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancerP C Clahsen, C J van de Velde, C Duval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancerP C Clahsen, C J van de Velde, C Duval, et al.
British Journal of Cancer|July 1, 1996
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapyH J van Slooten, P C Clahsen, J H van Dierendonck, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|March 23, 2000
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerR Lidereau, F Eisinger, M H Champème, et al.
Journal of the National Cancer Institute|January 19, 1994
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisS M Scholl, C Pallud, F Beuvon, et al.
Cancer Research|May 15, 1987
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumorsM Perrot-Applanat, M T Groyer-Picard, F Lorenzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 27, 1999
The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancerP C Clahsen, C J van de Velde, C Duval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancerP C Clahsen, C J van de Velde, C Duval, et al.
British Journal of Cancer|July 1, 1996
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapyH J van Slooten, P C Clahsen, J H van Dierendonck, et al.
Pageof 3